mutLBSgeneDB |
Gene summary for AKR1D1 |
Gene summary |
Basic gene Info. | Gene symbol | AKR1D1 |
Gene name | aldo-keto reductase family 1, member D1 | |
Synonyms | 3o5bred|CBAS2|SRD5B1 | |
Cytomap | UCSC genome browser: 7q32-q33 | |
Type of gene | protein-coding | |
RefGenes | NM_001190906.1, NM_001190907.1,NM_005989.3, | |
Description | 3-oxo-5-beta-steroid 4-dehydrogenasedelta 4-3-ketosteroid-5-beta-reductasedelta(4)-3-ketosteroid 5-beta-reductasedelta(4)-3-oxosteroid 5-beta-reductasesteroid-5-beta-reductase, beta polypeptide 1 (3-oxo-5 beta-steroid delta 4-dehydrogenase beta 1) | |
Modification date | 20141211 | |
dbXrefs | MIM : 604741 | |
HGNC : HGNC | ||
Ensembl : ENSG00000122787 | ||
HPRD : 07263 | ||
Vega : OTTHUMG00000155787 | ||
Protein | UniProt: P51857 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_AKR1D1 | |
BioGPS: 6718 | ||
Pathway | NCI Pathway Interaction Database: AKR1D1 | |
KEGG: AKR1D1 | ||
REACTOME: AKR1D1 | ||
Pathway Commons: AKR1D1 | ||
Context | iHOP: AKR1D1 | |
ligand binding site mutation search in PubMed: AKR1D1 | ||
UCL Cancer Institute: AKR1D1 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0006699 | bile acid biosynthetic process | 7508385 | GO:0006707 | cholesterol catabolic process | 7508385 | GO:0007586 | digestion | 7508385 | GO:0008207 | C21-steroid hormone metabolic process | 7508385 | GO:0008209 | androgen metabolic process | 7508385 | GO:0055114 | oxidation-reduction process | 7508385 |
Top |
Ligand binding site mutations for AKR1D1 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | A256 | A255E | COAD | 1 | D53 | I52V | HNSC | 1 | Y132 | P133H | LUAD | 1 | L239 | L239V | LUAD | 1 | V231 | V233D | LUSC | 1 | R279 | R279K | SKCM | 1 | K273 | K273R | SKCM | 1 | I131 | E130K | SKCM | 1 | K273 | K273N | SKCM | 1 | N283 | N283K | UCEC | 1 | S169 | V168M | UCEC | 1 | M313,L311 | L312F | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for AKR1D1 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | R279 | R279K | -1.5848302 | L311 | L312F | -1.379391 | M313 | L312F | -1.379391 | K273 | K273N | -1.2986496 | N283 | N283K | -1.2622247 | D53 | I52V | -1.2003417 | L239 | L239V | -1.0611238 | S169 | V168M | -1.0551524 | K273 | K273R | -0.98853512 | Y132 | P133H | -0.94236489 | V231 | V233D | -0.74476912 | I131 | E130K | -0.61440033 | A256 | A255E | -0.5035316 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for AKR1D1 from PDB |
Top |
Differential gene expression and gene-gene network for AKR1D1 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for AKR1D1 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C1856127 | Bile acid synthesis defect, congenital, 2 | 3 | Biomarker, GeneticVariation |
umls:C0018995 | Hemochromatosis | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for AKR1D1 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Approved | DB00548 | Azelaic Acid | Small molecule | |
Approved | DB01216 | Finasteride | Small molecule | |
Experimental | DB07447 | 5-beta-DIHYDROTESTOSTERONE | Small molecule | |
Experimental | DB07557 | (5BETA)-PREGNANE-3,20-DIONE | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of AKR1D1 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | NAP | NADP ZWITTERION | 3bur | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3bur | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3buv | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3buv | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3bv7 | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3bv7 | B | D53 S169 L239 A256 K273 R279 N283 | NDP | NADPH | 3caq | A | D53 S169 L239 A256 K273 R279 N283 | NDP | NADPH | 3caq | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cas | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cas | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cav | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cav | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cmf | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cmf | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cot | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3cot | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3dop | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3dop | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3g1r | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3g1r | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzw | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzw | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzx | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzx | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzy | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzy | B | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzz | A | D53 S169 L239 A256 K273 R279 N283 | NAP | NADP ZWITTERION | 3uzz | B | D53 S169 L239 A256 K273 R279 N283 | EPE | HEPES | 3buv | A | I131 Y132 L311 | CI2 | 5BETA-PREGNANE-3,20-DIONE | 3cav | B | Y132 | STR | PROGESTERONE | 3cot | A | Y132 | BDT | 5BETA-DIHYDROTESTOSTERONE | 3dop | B | Y132 | AOX | EPIANDROSTERONE | 3uzx | B | Y132 | AOM | 5ALPHA-ANDROSTANE-3BETA,17BETA-DIOL | 3uzx | A | Y132 L311 | CI2 | 5BETA-PREGNANE-3,20-DIONE | 3cav | A | Y132 L311 M313 | PDN | PREDNISONE | 3cmf | A | Y132 L311 M313 | PDN | PREDNISONE | 3cmf | B | Y132 L311 M313 | BDT | 5BETA-DIHYDROTESTOSTERONE | 3uzy | A | Y132 L311 M313 | BDT | 5BETA-DIHYDROTESTOSTERONE | 3uzy | B | Y132 L311 M313 | ASD | ANDROST-4-ENE-3,17-DIONE | 3uzz | B | Y132 L311 M313 | FIT | FINASTERIDE | 3g1r | B | Y132 M313 | TES | TESTOSTERONE | 3uzz | A | Y132 M313 | TES | TESTOSTERONE | 3bur | A | Y132 V231 | TES | TESTOSTERONE | 3bur | B | Y132 V231 | ASD | ANDROST-4-ENE-3,17-DIONE | 3cas | A | Y132 V231 | ASD | ANDROST-4-ENE-3,17-DIONE | 3cas | B | Y132 V231 |
Top |
Conservation information for LBS of AKR1D1 |
Multiple alignments for P51857 in multiple species |
LBS | AA sequence | # species | Species | A256 | YNKTQAQIVLR | 2 | Mus musculus, Rattus norvegicus | A256 | YNKTAAQIVLR | 1 | Homo sapiens | D53 | GYRHIDGAYVY | 2 | Mus musculus, Rattus norvegicus | D53 | GYRHIDGAYIY | 1 | Homo sapiens | E120 | DLYIIEVPMAF | 1 | Homo sapiens | E120 | DLYIIELPMAF | 1 | Mus musculus | E120 | DLYIIEMPMAF | 1 | Rattus norvegicus | E282 | PERIKENFQIF | 2 | Mus musculus, Rattus norvegicus | E282 | LERIKENFQIF | 1 | Homo sapiens | F275 | VIPKSFNLERI | 1 | Homo sapiens | F275 | VIPKSFTPERI | 1 | Mus musculus | F275 | VIPKSTTPERI | 1 | Rattus norvegicus | G223 | AYSPLGTSRNP | 1 | Homo sapiens | G223 | AHSPLGTCRNP | 1 | Mus musculus | G223 | AYSPLGTCRNP | 1 | Rattus norvegicus | G24 | PIIGLGTYSEP | 1 | Homo sapiens | G24 | PLIGLGTYSDP | 1 | Mus musculus | G24 | PIIGLGTYSDP | 1 | Rattus norvegicus | I131 | KPGDEIYPRDE | 1 | Homo sapiens | I131 | KPGKEIYPRDE | 1 | Mus musculus | I131 | KPGEEFYPKDE | 1 | Rattus norvegicus | I229 | TSRNPIWVNVS | 1 | Homo sapiens | I229 | TCRNPSWVNVS | 1 | Mus musculus | I229 | TCRNPLWVNVS | 1 | Rattus norvegicus | I271 | RGVVVIPKSFN | 1 | Homo sapiens | I271 | RGIVVIPKSFT | 1 | Mus musculus | I271 | RGLVVIPKSTT | 1 | Rattus norvegicus | I57 | IDGAYIYQNEH | 1 | Homo sapiens | I57 | IDGAYVYHNEH | 1 | Mus musculus | I57 | IDGAYVYRNEH | 1 | Rattus norvegicus | K273 | VVVIPKSFNLE | 1 | Homo sapiens | K273 | IVVIPKSFTPE | 1 | Mus musculus | K273 | LVVIPKSTTPE | 1 | Rattus norvegicus | K87 | IFYCGKLWATN | 1 | Homo sapiens | K87 | IFYCGKLWNTE | 1 | Mus musculus | K87 | IFYCGKLWSTD | 1 | Rattus norvegicus | L222 | TAYSPLGTSRN | 1 | Homo sapiens | L222 | VAHSPLGTCRN | 1 | Mus musculus | L222 | VAYSPLGTCRN | 1 | Rattus norvegicus | L239 | SSPPLLKDALL | 1 | Homo sapiens | L239 | SSPPLLNDELL | 1 | Mus musculus | L239 | SSPPLLKDELL | 1 | Rattus norvegicus | L311 | VRFVELLMWRD | 1 | Homo sapiens | L311 | VRYVELLMWSD | 1 | Mus musculus | L311 | VRFVEMLMWSD | 1 | Rattus norvegicus | M313 | FVELLMWRDHP | 1 | Homo sapiens | M313 | YVELLMWSDHP | 1 | Mus musculus | M313 | FVEMLMWSDHP | 1 | Rattus norvegicus | N170 | SLGVSNFNRRQ | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | N227 | LGTSRNPIWVN | 1 | Homo sapiens | N227 | LGTCRNPSWVN | 1 | Mus musculus | N227 | LGTCRNPLWVN | 1 | Rattus norvegicus | N283 | ERIKENFQIFD | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | P221 | ITAYSPLGTSR | 1 | Homo sapiens | P221 | IVAHSPLGTCR | 1 | Mus musculus | P221 | IVAYSPLGTCR | 1 | Rattus norvegicus | P272 | GVVVIPKSFNL | 1 | Homo sapiens | P272 | GIVVIPKSFTP | 1 | Mus musculus | P272 | GLVVIPKSTTP | 1 | Rattus norvegicus | Q193 | KPVTNQVECHP | 2 | Mus musculus, Rattus norvegicus | Q193 | KPVSNQVECHP | 1 | Homo sapiens | R226 | PLGTSRNPIWV | 1 | Homo sapiens | R226 | PLGTCRNPSWV | 1 | Mus musculus | R226 | PLGTCRNPLWV | 1 | Rattus norvegicus | R279 | SFNLERIKENF | 1 | Homo sapiens | R279 | SFTPERIKENF | 1 | Mus musculus | R279 | STTPERIKENF | 1 | Rattus norvegicus | S169 | KSLGVSNFNRR | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | S220 | VITAYSPLGTS | 1 | Homo sapiens | S220 | VIVAHSPLGTC | 1 | Mus musculus | S220 | FIVAYSPLGTC | 1 | Rattus norvegicus | S225 | SPLGTSRNPIW | 1 | Homo sapiens | S225 | SPLGTCRNPSW | 1 | Mus musculus | S225 | SPLGTCRNPLW | 1 | Rattus norvegicus | S274 | VVIPKSFNLER | 1 | Homo sapiens | S274 | VVIPKSFTPER | 1 | Mus musculus | S274 | VVIPKSTTPER | 1 | Rattus norvegicus | T224 | YSPLGTSRNPI | 1 | Homo sapiens | T224 | HSPLGTCRNPS | 1 | Mus musculus | T224 | YSPLGTCRNPL | 1 | Rattus norvegicus | T25 | IIGLGTYSEPK | 1 | Homo sapiens | T25 | LIGLGTYSDPR | 1 | Mus musculus | T25 | IIGLGTYSDPR | 1 | Rattus norvegicus | V231 | RNPIWVNVSSP | 1 | Homo sapiens | V231 | RNPSWVNVSSP | 1 | Mus musculus | V231 | RNPLWVNVSSP | 1 | Rattus norvegicus | V309 | KNVRFVELLMW | 1 | Homo sapiens | V309 | KNVRYVELLMW | 1 | Mus musculus | V309 | KNVRFVEMLMW | 1 | Rattus norvegicus | W140 | DENGKWLYHKS | 1 | Homo sapiens | W140 | DENGRIIYDKT | 1 | Mus musculus | W140 | DENGRVIYHKS | 1 | Rattus norvegicus | W230 | SRNPIWVNVSS | 1 | Homo sapiens | W230 | CRNPSWVNVSS | 1 | Mus musculus | W230 | CRNPLWVNVSS | 1 | Rattus norvegicus | W314 | VELLMWRDHPE | 1 | Homo sapiens | W314 | VELLMWSDHPE | 1 | Mus musculus | W314 | VEMLMWSDHPE | 1 | Rattus norvegicus | W89 | YCGKLWATNHV | 1 | Homo sapiens | W89 | YCGKLWNTEHV | 1 | Mus musculus | W89 | YCGKLWSTDHD | 1 | Rattus norvegicus | Y132 | PGDEIYPRDEN | 1 | Homo sapiens | Y132 | PGKEIYPRDEN | 1 | Mus musculus | Y132 | PGEEFYPKDEN | 1 | Rattus norvegicus | Y219 | IVITAYSPLGT | 1 | Homo sapiens | Y219 | IVIVAHSPLGT | 1 | Mus musculus | Y219 | SFIVAYSPLGT | 1 | Rattus norvegicus | Y26 | IGLGTYSDPRP | 2 | Mus musculus, Rattus norvegicus | Y26 | IGLGTYSEPKS | 1 | Homo sapiens | Y58 | DGAYIYQNEHE | 1 | Homo sapiens | Y58 | DGAYVYHNEHE | 1 | Mus musculus | Y58 | DGAYVYRNEHE | 1 | Rattus norvegicus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |